November 7, 2016 / 7:42 AM / 9 months ago

BRIEF-Zhejiang CONBA Pharmaceutical unit gets nod for clinic trial

Nov 7 (Reuters) - Zhejiang CONBA Pharmaceutical Co Ltd :

* Says its unit gets China Food and Drug Administration's approval for clinic trial of a drug for preventing thrombus of atherosclerosis and acute coronary artery syndrome

Source text in Chinese: goo.gl/0T3mno

Further company Coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below